-
Circular RNA Vaccines: Design, Evidence, and Limits
2026-09-23
Niu, Wu, and Lian review how engineered circular RNAs could expand RNA vaccination through a stable, closed-loop architecture that can encode antigens. They examine design, synthesis, purification, and delivery approaches, while emphasizing that optimization and evaluation are still needed before the platform’s potential can be judged across diseases.
-
SMC2 and SMC4 as Breast Cancer Prognostic Markers
2026-09-23
A 2024 study combined multi-database bioinformatics, clinical survival analysis, cell assays, and xenograft experiments to identify SMC2 and SMC4 as independent prognostic factors in breast cancer. Its drug-sensitivity results further suggest that SMC2 or SMC4 interference can increase the response of MCF7 cells to 5-fluorouracil and oxaliplatin, although prospective clinical validation remains necessary.
-
Precision PCR for Neurodegeneration Research
2026-09-22
Mechanistic studies of environment-driven neurodegeneration demand molecular workflows that preserve sequence accuracy across difficult templates. This thought-leadership article connects pheromone-dependent neurobiology in C. elegans with strategic PCR design, showing how HyperFusion™ high-fidelity DNA polymerase can strengthen validation, cloning, genotyping, and sequencing workflows without overstating what a model-organism study can establish.
-
Vitamin C and ROS–Iron–Calcium Signaling in Osteosarcoma
2026-09-22
This study shows that pharmacological vitamin C suppresses human osteosarcoma through a redox-dependent cascade linking reactive oxygen species, iron, IP3R-mediated calcium release, and mitochondrial dysfunction. Its comparative redox-form design and integration of cell, transcriptomic, metabolic, and xenograft evidence provide a useful framework for assigning mechanism in non-apoptotic cancer cell death.
-
RSL3: Mapping Metabolic Control of Ferroptosis
2026-09-21
RSL3 is a glutathione peroxidase 4 inhibitor that exposes how lactate transport and metabolic stress shape ferroptosis. This article translates bladder-cancer findings into a metabolic-state-aware framework for oxidative stress, lipid peroxidation, and cancer assay design.
-
Oxaliplatin Beyond Cytotoxicity: A Translational Playbook
2026-09-21
Oxaliplatin is more than a DNA-damaging cytotoxin: its value in translational research lies in testing how drug-specific lesions, DNA repair context, model choice, and assay design shape response. This article connects mechanistic evidence with reproducible workflows and biomarker strategy.
-
Sulfo-NHS-Biotin for Translational Phage Diagnostics
2026-09-20
A thought-leadership framework for combining surface-selective biotinylation with phage-layer interferometry to connect molecular binding data with translational phage-screening decisions.
-
HyperFusion high-fidelity DNA polymerase workflows
2026-09-19
Learn how a proofreading DNA polymerase can improve difficult PCR, C. elegans genotyping, construct validation, and sequencing-library preparation. This workflow-centered guide covers GC-rich and long templates, blunt-end cloning, quantified setup conditions, and practical troubleshooting.
-
Ko 143 in BCRP Transporter Assays
2026-09-18
Learn how Ko 143, SKU A3533, can help distinguish BCRP-mediated drug efflux from nonspecific assay variability in viability, cytotoxicity, and pharmacokinetic studies. This scenario-based guide covers experimental design, solvent compatibility, protocol optimization, data interpretation, and practical product selection.
-
Fad2, Acsl4, and Rice Blast Pathogenicity
2026-09-18
A 2024 study links Fad2- and Acsl4-dependent polyunsaturated phospholipid biosynthesis with ferroptosis-associated development and pathogenicity in Magnaporthe oryzae. Mutant phenotyping, targeted lipidomics, oxidative perturbation, and redox-interaction analysis together identify PUFA-containing phospholipids as a mechanistic connection between fungal cell death and rice blast infection.
-
Angiotensin 1/2 (5-7) in RAS Research
2026-09-17
Angiotensin 1/2 (5-7) enables controlled studies of short angiotensin-fragment activity in cardiovascular assays and spike–receptor binding models. This workflow guide covers solution preparation, comparative controls, assay design, and troubleshooting for reproducible renin-angiotensin system research.
-
Oxaliplatin Workflows for DNA-Damage Research
2026-09-17
Build more reproducible Oxaliplatin assays by connecting fresh-solution handling, exposure timing, apoptosis readouts, and resistance biology. The workflow translates evidence from hepatocellular carcinoma models into practical combination, sequencing, and troubleshooting strategies for cancer chemotherapy research.
-
Repaglinide as a Metabolic Control in DNA-Repair Studies
2026-09-16
Repaglinide is best understood as a beta-cell stimulus-secretion probe, not an AML therapy. This article explains how its pharmacology can sharpen experimental controls around energy stress, ATG4B nuclear translocation, PRMT1-MRE11 signaling, and DNA-repair interpretation.
-
Diuron Research Workflows for Plant and Kidney Toxicology
2026-09-16
Diuron supports a two-track research strategy: controlled photosynthesis inhibition in plant biology research and mechanistic toxicology in renal cell models. This workflow translates its solvent, storage, and assay characteristics into reproducible screening, pathway validation, and troubleshooting decisions.
-
EphA2 Synthetic Lethality in MYC-Driven TNBC
2026-09-15
A chemogenetic kinase-inhibitor screen identified EphA2 as a synthetic lethal vulnerability in MYC-driven triple-negative breast cancer. The study links the EphA2 inhibitor ALW-II-41-27 to MYC-selective intrinsic apoptosis, activity across p53 contexts, and tumor-growth suppression in TNBC xenografts, while also defining important limitations for translational interpretation.